Primary central nervous system mucosa-associated lymphoid tissue lymphoma: Case report and literature review

Clinical Lymphoma and Myeloma

Volumn 9, Issue 3, 2009, Pages

  Razaq, Wajeeha ^a,b   Goel, Anupama ^a,b   Amin, Ali ^a,b   Grossbard, Michael ^a,b,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b New York Cardiovascular Research   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Marginal zone B cell lymphoma; Meningioma; Primary dural lymphomas; Rituximab; Trisomy 3

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; CYCLOPHOSPHAMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE PARALYSIS; CRANIOTOMY; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MARGINAL ZONE LYMPHOMA; MENINGIOMA; MOTOR DYSFUNCTION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; RELAPSE; T LYMPHOCYTE; CASE REPORT; CHROMOSOME 3; GENETICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TRISOMY; ULTRASTRUCTURE;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MENINGIOMA; MIDDLE AGED; RECURRENCE; TRISOMY;

EID: 69149104918     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.052     Document Type: Article

References (17)

1. Krogh-Jensen M, d'Amore F, Jensen MK, et al. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Ann Oncol 1994; 5:349-54.
2. Kambham N, Chang Y, Matsushima AY. Primary low grade B cell lymphoma of mucosa associated lymphoid tissue (MALT) arising in dura. Clin Neuropathol 1998; 17:311-7.
3. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52:1410-6.
4. Lachance D, O'Neil B, Macdonald D, et al. Primary leptomeningeal lymphoma. Report of 9 cases, diagnosis with immunocytochemical analysis and review of the literature. Neurology 1991; 41:95.
5. Huller GN, Burger PC. Central nervous system. In: Sternberg SS (ed). Histopathology for Pathologist. New York: Raven, 1992; 145-68.
6. Tu PH, Giannini C, Judkins A, et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low grade CNS lymphoma that mimics meningioma. J Clin Oncol 2005; 23:5718-27.
7. Goetz P, Lafuente J, Revesz T, et al. Primary low grade B cell lymphoma of mucosa associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma. J Neurosurg 2002; 96:611-4.
8. Iwamoto FM, DeAngelis LM, Abrey LE, et al. Pimary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 2006; 66:1763-5.
9. Miranda RN, Glantz LK, Myint MA, et al. Stage IE non-Hodgkin's lymphoma arising from the dura: a clinicopathologic study of five cases. Arch Pathol Lab Med 1996; 120:254-60.
10. Itoh T, Shimizu M, Kitami K, et al. Primary extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue type in the CNS. Neuropathology 2001; 21:174-80.
11. Maes B, de Wolf-Peeters C. Marginal zone B cell lymphoma: an update on recent advances. Histopathology 2002; 40:117-26.
12. Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumors of the central nervous system, 4th edition. International Agency for Research on Cancer (IARC) 2007; 188-92.
13. Burger PC, Scheithauser BW, Vogel FS. Surgical Pathology of the Nervous System and its Coverings. 4th ed. New York: Churchill Livingstone; 2002:317-23.
14. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low grade B-cell ymphoma of mucosa associated lymphoid tissue. Oncogene 1999; 18:5785-94.
15. Iwamoto FM, DeAngelis LM, Abrey LE. Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 2006; 66:1763-5.
16. Puri D, Tereffe W, Yahalom J. Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data. Int J Radiat Oncol Biol Phys 2008; 71:1425-35.
17. Assaf C, Coupland SE, Hummel M. Relapse of primary extranodal marginal zone B cell lymphoma of the dura mater. Lancet Oncol 2005; 6:187-9.